ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting
Oral administration of OBE022 shows favorable safety and results in predictable exposure Non-clinical results of OBE022 for PTL demonstrating fetal safety Geneva, Switzerland and Boston, MA - 01 March 2018 - ObsEva SA (Nasdaq: OBSV), a Swiss …